Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 7, 2008, Pages 1259-1271

  Vente, M A D ^a   Nijsen, J F W ^a   De Wit, T C ^a   Seppenwoolde, J H ^b   Krijger, G C ^c   Seevinck, P R ^b   Huisman, A ^a   Zonnenberg, B A ^a   Van Den Ingh, T S G A M ^d   Van Het Schip, A D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d TCCI Consultancy BV   (Netherlands)

Author keywords

Holmium; Internal radiation therapy; Liver malignancies; Microspheres

Indexed keywords

HOLMIUM; HOLMIUM 165 MICROSPHERE; HOLMIUM 166 POLYLACTIC ACID; MICROSPHERE; POLYLACTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CATHETER OCCLUSION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG MEGADOSE; FEMALE; HEPATIC ARTERY; ISOTOPE LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; TOXICITY TESTING;

ANIMALS; CATHETERIZATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HOLMIUM; HUMANS; LACTIC ACID; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MICROSPHERES; POLYMERS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; SWINE; TISSUE DISTRIBUTION;

EID: 45049086477     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0747-8     Document Type: Article

References (45)

1. Garrean S, Muhs A, Bui JT, Blend MJ, Owens C, Helton WS, et al. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT. World J Gastroenterol 2007;13:3016-9.
2. Sato K, Lewandowski RJ, Bui JT, Omary R, Hunter RD, Kulik L, et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere(R)): assessment of hepatic arterial embolization. Cardiovasc Interv Radiol 2006;29:522-9.
3. Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, et al. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;66:792-800.
4. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE Jr., Loehr SP, et al. Resin (90)Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006;65:412-25.
5. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised phase 2 trial of SIR-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78-85.
6. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994;35:1637-44.
7. Nijsen JFW, Van het Schip AD, Hennink WE, Rook DW, Van Rijk PP, De Klerk JMH. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver metastases. Current Med Chem 2002;9:73-82.
8. Ho S, Lau JW, Leung TW. Intrahepatic (90)Y-microspheres for hepatocellular carcinoma. J Nucl Med 2001;42:1587-9.
9. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 2005;25(Suppl 1):S41-55.
10. Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 2005;16:937-45.
11. Popperl G, Helmberger T, Munzing W, Schmid R, Jacobs TF, Tatsch K. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 2005;20:200-8.
12. De Wit TC, Xiao J, Nijsen JF, Van het Schip AD, Staelens SG, Van Rijk PP, et al. Hybrid scatter correction applied to quantitative holmium-166 SPECT. Phys Med Biol 2006;51:4773-87.
13. Ho S, Lau WY, Leung TW, Chan M, Chan KW, Lee WY, et al. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 1997;70:823-8.
14. Seppenwoolde JH, Nijsen JF, Bartels LW, Zielhuis SW, Van het Schip AD, Bakker CJ. Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 2004;53:76-84.
15. Nijsen JF, Seppenwoolde JH, Havenith T, Bos C, Bakker CJ, Van het Schip AD. Liver tumors: MR imaging of radioactive holmium microspheres-phantom and rabbit study. Radiology 2004;231:491-9.
16. Seppenwoolde JH, Bartels LW, Van der Weide R, Nijsen JF, Van het Schip AD, Bakker CJ. Fully MR-guided hepatic artery catheterization for selective drug delivery: a feasibility study in pigs. J Magn Reson Imaging 2006;23:123-9.
17. Zielhuis SW, Nijsen JF, Dorland L, Krijger GC, Van het Schip AD, Hennink WE. Removal of chloroform from biodegradable therapeutic microspheres by radiolysis. Int J Pharm 2006;315:67-74.
18. Zielhuis SW, Nijsen JFW, De Roos R, Krijger GC, Van Rijk PP, Hennink WE, et al. Production of GMP-grade radioactive holmium loaded poly(l-lactic acid) microspheres for clinical application. Int J Pharm 2006;311:69-74.
19. Nijsen JFW, Van het Schip AD, Van Steenbergen MJ, Zielhuis SW, Kroon-Batenburg LM, Van de Weert M, et al. Influence of neutron irradiation on holmium acetylacetonate loaded poly(l-lactic acid) microspheres. Biomaterials 2002;23:1831-9.
20. Nijsen F, Rook D, Brandt C, Meijer R, Dullens H, Zonnenberg B, et al. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med 2001;28:743-9.
21. Nijsen JFW. Radioactive holmium poly(L-lactic acid) microspheres for treatment of hepatic malignancies: efficacy in rabbits. PhD thesis Utrecht University, The Netherlands 2001, pp. 109-122. ISBN 90-393-2685-1.
22. Vente MA, Hobbelink MG, Van het Schip AD, Zonnenberg BA, Nijsen JF. Radionuclide liver cancer therapies: from concept to current clinical status. Anticancer Agents Med Chem 2007;7:441-59.
23. Nijsen JFW, Zonnenberg BA, Woittiez JR, Rook DW, Swildens-Van Woudenberg IA, Van Rijk PP, et al. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 1999;26:699-704.
24. Zielhuis SW, Nijsen JFW, Figueiredo R, Feddes B, Vredenberg AM, Van het Schip AD, et al. Surface characteristics of holmium-loaded poly(l-lactic acid) microspheres. Biomaterials 2005;26:925-32.
25. Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. J Pharmacokinet Biopharm 1980;8:165-76.
26. Dondelinger RF, Ghysels MP, Brisbois D, Donkers E, Snaps FR, Saunders J, et al. Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 1998;8:1254-73.
27. Faustini M, Munari E, Colombani C, Russo V, Maffeo G, Vigo D. Haematology and plasma biochemistry of Stamboek pre-pubertal gilts in Italy: reference values. J Vet Med A Physiol Pathol Clin Med 2000;47:525-32.
28. Hannon JP, Bossone CA, Wade CE. Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 1990;40:293-8.
29. Odink J, Smeets JF, Visser IJ, Sandman H, Snijders JM. Hematological and clinicochemical profiles of healthy swine and swine with inflammatory processes. J Anim Sci 1990;68:163-70.
30. Guise HJ, Carlyle WW, Penny RH, Abbott TA, Riches HL, Hunter EJ. Gastric ulcers in finishing pigs: their prevalence and failure to influence growth rate. Vet Rec 1997;141:563-6.
31. Sidikou DI, Banga-Mboko H, Tamboura HH, Hornick JL, Remy B, Beckers JF. Correlation between a proteolytic method and a radioimmunoassay for porcine serum pepsinogen concentrations. Res Vet Sci 2006;80:260-6.
32. Banga-Mboko H, Tamboura H, Maes D, Traoré H, Youssao I, Sangild PT, et al. Survey of gastric lesions and blood pepsinogen levels in pigs in burkina faso. Vet Res Commun 2003;27:595-602.
33. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007;18:553-61.
34. Salem R, Thurston KG, Carr BI, Goin JE, Geschwindt JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13:S223-9.
35. Cromheecke M, Konings AW, Szabo BG, Hoekstra HJ. Liver tissue tolerance for irradiation: experimental and clinical investigations. Hepatogastroenterology 2000;47:1732-40.
36. Ingold J, Reed G, Kaplan H, Bagshaw M. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-8.
37. Zielhuis SW, Nijsen JFW, Seppenwoolde JH, Bakker CJG, Krijger GC, Dullens HFJ, et al. Long-term toxicity of holmium loaded poly(l-lactic acid) microspheres in rats. Biomaterials 2007;28:4591-9.
38. Zielhuis SW, Nijsen JFW, Krijger GC, Van het Schip AD, Hennink WE. Holmium-loaded poly(l-lactic acid) microspheres: in vitro degradation study. Biomacromolecules 2006;7:2217-23.
39. Van Es RJ, Nijsen JF, Van het Schip AD, Dullens HF, Slootweg PJ, Koolen R. Intra-arterial embolization of head-and-neck cancer with radioactive holmium-166 poly(l-lactic acid) microspheres: an experimental study in rabbits. Int J Oral Maxillofac Surg 2001;30:407-13.
40. Jeppsson B, Dahl EP, Fredlund PE, Stenram U, Bengmark S. Hepatic necrosis in the pig produced by transient arterial occlusion. Eur Surg Res 1979;11:243-53.
41. Garrean S, Espat NJ. Yttrium-90 internal radiation therapy for hepatic malignancy. Surg Oncol 2005;14:179-93.
42. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S211-21.
43. Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:321-6.
44. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Angi C. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004;15:335-45.
45. Miller FH, Keppke AL, Reddy D, Huang J, Jin J, Mulcahy MF, et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. Am J Roentgenol 2007;188:776-83.